Jennifer Petter: Opportunities for RNA-Targeted Therapeutics

episode

Back of the Napkin - Inspiring Stories from Biotech Pioneers not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Legally Brunette Presents: ‘Til Death Do Us Part - Caleb Flynn (Pt. 1) 47 min · 27 Sep 2026 · Amy Robach & T.J. Holmes Present

Legally Brunette Presents: ‘Til Death Do Us Part - Caleb Flynn (Pt. 1) 47 min · 27 Sep 2026 · Two Ts In A Pod with Teddi Mellencamp and Tamra Judge

Insider Reveals the Leaks in WH and Trump’s Hidden Secret 1h 1m · 27 Sep 2026 · IHIP News

Is New Zealand COSTING Its People By Giving TOO Much?! 57 min · 27 Sep 2026 · THE MORNING SHIFT

The Capital Mirage: Why Being Broke is Your Greatest Strategic Advantage 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

Four Men. One Bipolar Mind 1h 11m · 27 Sep 2026 · We're All Insane

Report any issue

Source

Recorded09 Jun 2023

Publisherfeeds.zencastr.com ↗

Handlerec:4638147

Show notes

Jennifer Petter is the founder and Chief Innovation Officer at Arrakis Therapeutics. Here she discusses the moments that led up to the founding of a successful biotech company built on a remarkable new approach in drug discovery: RNA-targeting small molecules. This back of the napkin conversation covers the standout moments in Jen’s career as well as some insightful perspectives into the future of drug discovery.Arrakis Therapeutics Website: https://arrakistx.com/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in